These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14327964)

  • 21. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 22. [ANTIMICROBIAL SCREEN IN PHTHISIOLOGICAL SURGERY].
    SNAJDR V; KRAKORA P; FISER F; CHODOUNSKA V
    Rozhl Chir; 1963 Oct; 42():712-20. PubMed ID: 14119837
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of urogenital tuberculosis with current drugs].
    König K; May P
    Urologe; 1968; 7(1):23-9. PubMed ID: 4297580
    [No Abstract]   [Full Text] [Related]  

  • 26. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 27. [ASSOCIATION OF 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND PYRAZINAMIDE, AND 4,4'-DIISOAMYLOXYTHIOCARBANILIDE AND KANAMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE 1ST LINE DRUGS].
    PEREZ JA; FARIAS CE; BRONSTEIN DL; CONTRERAS H; MUNARO N
    Sem Med; 1964 Mar; 124():549-54. PubMed ID: 14158157
    [No Abstract]   [Full Text] [Related]  

  • 28. ["2ND LINE" DRUG THERAPY IN CHRONIC TUBERCULOSIS DUE TO GERM RESISTANCE. (NEW METHODS OF DRUG ADMINISTRATION; NEW DRUGS)].
    HAMMERLI A; KRAMER EE; GALLINDO IS
    Hospital (Rio J); 1964 Feb; 65():365-88. PubMed ID: 14136756
    [No Abstract]   [Full Text] [Related]  

  • 29. [ETHIONAMIDE IN ASSOCIATION WITH PYRAZINAMIDE OR CYCLOSERINE IN THE TREATMENT OF CHRONIC PULMONARY TUBERCULOSIS].
    WAGNER J
    Gruzlica (1926); 1963 Dec; 31():1217-22. PubMed ID: 14107826
    [No Abstract]   [Full Text] [Related]  

  • 30. RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
    PFUETZE KH; PYLE MM
    JAMA; 1964 Mar; 187():805-10. PubMed ID: 14094316
    [No Abstract]   [Full Text] [Related]  

  • 31. The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.
    PINES A
    Br J Dis Chest; 1962 Oct; 56():163-70. PubMed ID: 13943667
    [No Abstract]   [Full Text] [Related]  

  • 32. The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
    Krivinka R; Tousek J
    Antibiot Chemother; 1970; 16():215-21. PubMed ID: 4108889
    [No Abstract]   [Full Text] [Related]  

  • 33. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G; CATTANEO C
    Ann Ist Carlo Forlanini; 1962; 22():326-65. PubMed ID: 14026068
    [No Abstract]   [Full Text] [Related]  

  • 34. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 35. TREATMENT OF PATIENTS WITH CULTURES RESISTANT TO THE PRIMARY ANTI-TUBERCULOSIS DRUGS.
    ZIERSKI M
    Tubercle; 1964 Jun; 45():96-100. PubMed ID: 14161919
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
    [No Abstract]   [Full Text] [Related]  

  • 37. SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID.
    TANI P; POPPIUS H
    Acta Tuberc Pneumol Scand; 1963; 43():256-64. PubMed ID: 14072347
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC
    Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
    [No Abstract]   [Full Text] [Related]  

  • 39. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug therapy of tuberculosis].
    Jentgens H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1627-30. PubMed ID: 4135677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.